Catez E, Sina B, De Coodt P, Peperstraete B, Ngoc E Tran, Castro J, Morissens M, Flores G, Strachinaru M, Verbeet T
Département de Cardiologie, C.H.U. Brugmann, Bruxelles.
Rev Med Brux. 2011 Sep;32(4):328-41.
Some new guidelines have been published by European (2010) and American (2011) Societies of Cardiology regarding to the management of atrial fibrillation, the most frequent arrhythmia affecting from 1 to 2% of the global population. In this article we summarize and analyse the new aspects of these guidelines in which the different types of atrial fibrillation are redefined, as well as new criterias for the indication of oral anticoagulation and bleeding risk. New antiarrhythmic and anticoagulant molecules also appear in these guidelines, and there is growing evidence for the use of catheter ablation.
欧洲心脏病学会（2010年）和美国心脏病学会（2011年）已发布了一些关于心房颤动管理的新指南，心房颤动是最常见的心律失常，影响全球1%至2%的人口。在本文中，我们总结并分析了这些指南的新内容，其中重新定义了不同类型的心房颤动，以及口服抗凝治疗的指征和出血风险的新标准。这些指南中还出现了新的抗心律失常和抗凝药物，并且越来越多的证据支持使用导管消融术。
